NSIM
CMPX icon

North Star Investment Management’s Compass Therapeutics CMPX Stock Holding History

North Star Investment Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Hold
12,500
– – ﹤0.01% 863
2026
Q1 		$66.1K Hold
12,500
– – ﹤0.01% 670
2025
Q4 		$67.1K Hold
12,500
– – ﹤0.01% 614
2025
Q3 		$43.8K Hold
12,500
– – ﹤0.01% 688
2025
Q2 		$32.5K Hold
12,500
– – ﹤0.01% 719
2025
Q1 		$23.8K Hold
12,500
– – ﹤0.01% 735
2024
Q4 		$18.1K Hold
12,500
– – ﹤0.01% 780
2024
Q3 		$23K Buy
+12,500
New +$15.6K ﹤0.01% 711

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

North Star Investment Management's CMPX Position: Q2 2026 in Review

North Star Investment Management held its Compass Therapeutics (CMPX) position steady in Q2 2026 at 12,500 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

North Star Investment Management first reported a position in CMPX in Q3 2024 and has held it in 8 quarters since. The position peaked at $67.1K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • North Star Investment Management held 12,500 shares of Compass Therapeutics worth $27.4K as of Q2 2026.
  • North Star Investment Management left its Compass Therapeutics share count unchanged in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #863 holding.
  • North Star Investment Management first reported a position in Compass Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • North Star Investment Management's Compass Therapeutics position peaked at $67.1K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.